These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7235823)

  • 1. Ataxia caused by fluoxymesterone therapy in breast cancer.
    Agrawal BL
    Arch Intern Med; 1981 Jun; 141(7):958-9. PubMed ID: 7235823
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
    Ingle JN; Suman VJ; Mailliard JA; Kugler JW; Krook JE; Michalak JC; Pisansky TM; Wold LE; Donohue JH; Goetz MP; Perez EA
    Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurological manifestations in treatment with androgenic hormones].
    in 't Veld CJ; Bieger R; Mosmans PC
    Ned Tijdschr Geneeskd; 1983 Jun; 127(26):1154-5. PubMed ID: 6888577
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effect of fluoxymesterone in the treatment of recurrent and progressive breast neoplasms].
    Takaya O
    Horumon To Rinsho; 1977 Dec; 25(12):1371-84. PubMed ID: 598046
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of fluoxymesterone (Halotestin) on progressive breast cancer].
    Yoshida Y; Miura S; Takeuchi S
    Horumon To Rinsho; 1972 Aug; 20(8):655-66. PubMed ID: 4675689
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical evaluation of estrogen-androgen combination in advanced breast cancer.
    Haines CR; Wallace HJ; Nevinny HB; Hall TC
    Am J Surg; 1969 Apr; 117(4):589-94. PubMed ID: 4891037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Complex chemotherapeutic treatment of breast cancer].
    SELLEI C; KOROS Z
    Magy Onkol; 1962 Aug; 6():171-82. PubMed ID: 13987792
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluoxymesterone therapy in advanced breast cancer.
    KENNEDY BJ
    N Engl J Med; 1958 Oct; 259(14):673-5. PubMed ID: 13590423
    [No Abstract]   [Full Text] [Related]  

  • 9. Fluoxymesterone in the treatment of advanced breast cancer.
    KENNEDY BJ
    Cancer; 1957; 10(4):813-8. PubMed ID: 13472624
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor efficacy of fluoxymesterone. Use in advanced breast cancer.
    LOWE R; DE LORIMIER AA; GORDAN GS; GOLDMAN L
    Arch Intern Med; 1961 Feb; 107():241-4. PubMed ID: 13763814
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of 2,17-dimethyl testosterone and fluoxymesterone in metastatic breast cancer. Nonprogression--an index of tumor therapy evaluation.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; BECKETT VL
    Cancer; 1963 Apr; 16():440-3. PubMed ID: 13984784
    [No Abstract]   [Full Text] [Related]  

  • 12. COMPARISON OF 6-ALPHA-METHYL-9-ALPHA-FLUORO-17-ACETOXY-21-DEOXYPREDNISOLONE WITH FLUOXYMESTERONE AND METHYLPREDNISOLONE IN TREATMENT OF METASTATIC BREAST CANCER.
    TALLEY RW; BRENNAN MJ; VAITKEVICIUS VK; SANDIEGO EL; REED ML; LEIGHTON GA
    Cancer; 1964 Aug; 17():1063-6. PubMed ID: 14202593
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast cancer in two sisters with Friedreich's ataxia.
    Kidd A; Coleman R; Whiteford M; Barron LH; Simpson SA; Haites NE
    Eur J Surg Oncol; 2001 Aug; 27(5):512-4. PubMed ID: 11504527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ataxia-telangiectasia heterozygotes in familial breast cancer.
    Chen J; Birkholtz GG; Lindblom P; Rubio C; Lindblom A
    Cancer Res; 1998 Apr; 58(7):1376-9. PubMed ID: 9537233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced breast cancer with fluoxymesterone (halotestin).
    BECKETT VL; BRENNAN MJ
    Surg Gynecol Obstet; 1959 Aug; 109(2):235-9. PubMed ID: 13675999
    [No Abstract]   [Full Text] [Related]  

  • 16. Fluoxymesterone (halotestin) in the treatment of advanced breast cancer.
    OLSON KB
    N Y State J Med; 1959 Jan; 59(2):248-52. PubMed ID: 13622979
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast cancer incidence and the effect of cigarette smoking in heterozygous carriers of mutations in the ataxia-telangiectasia gene.
    Swift M; Lukin JL
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3188-92. PubMed ID: 18990761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adjuvant therapy for older patients with node (+) early breast cancer cost-effective?
    Naeim A; Keeler EB
    Breast Cancer Res Treat; 2005 Nov; 94(2):95-103. PubMed ID: 16261407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
    Olson JE; Neuberg D; Pandya KJ; Richter MP; Solin LJ; Gilchrist KW; Tormey DC; Veeder M; Falkson G
    Cancer; 1997 Mar; 79(6):1138-49. PubMed ID: 9070491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linkage analysis of DRD2, a marker linked to the ataxia-telangiectasia gene, in 64 families with premenopausal bilateral breast cancer.
    Cortessis V; Ingles S; Millikan R; Diep A; Gatti RA; Richardson L; Thompson WD; Paganini-Hill A; Sparkes RS; Haile RW
    Cancer Res; 1993 Nov; 53(21):5083-6. PubMed ID: 8221639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.